Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

(2011) Catherine Larochelle et al.   FEBS LETTERS

Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood

(2011) Martin Lundberg et al.   NUCLEIC ACIDS RESEARCH

Disruption of central nervous system barriers in multiple sclerosis

(2010) Jorge Ivan Alvarez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Structural insights into de novo actin polymerization

(2010) Roberto Dominguez   CURRENT OPINION IN STRUCTURAL BIOLOGY

Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia

(2010) S. McArthur et al.   JOURNAL OF IMMUNOLOGY

Rho Signaling and Tight Junction Functions

(2010) Steve Terry et al.   PHYSIOLOGY

Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization

(2009) Simon McArthur et al.   FASEB JOURNAL

Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1

(2009) Nikolaos Paschalidis et al.   Journal of Neuroinflammation

Structure and function of the blood–brain barrier

(2009) N. Joan Abbott et al.   NEUROBIOLOGY OF DISEASE

The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction

(2009) Britta Engelhardt et al.   Seminars in Immunopathology

Bradykinin increases blood–tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton

(2008) Li-bo Liu et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Annexin A1 in the brain – undiscovered roles?

(2008) Egle Solito et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Impaired phagocytic mechanism in annexin 1 null macrophages

(2006) Simon Yona et al.   BRITISH JOURNAL OF PHARMACOLOGY